Investors in Art

Siena Secondary Fund provides liquidity for early investors, founders and employees of high growth startups from the Nordics & CEE region. We target companies which are usually post series A, have solid business model and are still in high growth phase.

We stimulate growth through collaborative, strategic and transactional services. Our key expertise are: Market Intelligence, Transaction Advisory, Service Design, Innovation Strategy, Collaboration Projects and venture Building. In the early days of Vertical, we supported startups to become the best versions of themselves. We were great at what we did, yet along the way we noticed the changing needs of the market, and realised we could offer something even better. We adapted and grew into a new space, to focus on strategic development and using collaboration as a tool. When it comes to growth, strategy and collaboration, we don't just talk the talk: we walk the walk too.

Cross Ocean Ventures is the premier early-stage investor for ambitious high-growth technology companies that got their start in Europe and Israel. - That now plan to launch or expand their footprint in the US market. - And are currently on a feasible growth path to receive US Venture Capital led Series-A funding within the next 12-24 months.

GB & Partners is Hungary's largest independent venture and private equity fund management company, supporting portfolio companies with active operational involvement to ensure high returns and security for investors. They specialize in ambitious, game-changing ventures, providing strategic, sales, and professional support, contributing to the growth and prosperity of their investments. As a full member of Invest Europe, GB & Partners manages nearly HUF 80 billion in assets, covering a wide range of industries and geographical areas, achieving significant growth and record sales.

3LB Seed Capital is a privately owned holding company focused on seed investments in Italian startups form emerging sectors. 3LB Seed Capital enters into the start-ups equity essentially in the initial phases of their developments, more often as the first investor outside the circle of the founders. Our individual investments are generally sized between €30k and €60k; we invest in young entrepreneurs that really show us their strong focus and resilience in supporting their projects & ideas, and we establish with them a "business partners" relationship proper to angel investors. For larger investments, within the range of €500k, we share the risk with other investing partners, both individuals or investing syndicates and club-deals. Occasionally, when we have the opportunity to co-invest with our network of contacts in companies ahead in their development path, we follow with more significant funding rounds, beyond the threshold of 1 M€.

Claris Ventures SGR makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence. We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence. Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing" (or the relevant translation).

We partner with stellar entrepreneurs to realize their unique intuitions and reach their goals, inspired by values. Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and our advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources. We are sector agnostic and target innovative opportunities around the world. We share goals and passion with founders and look to connect them with our wide international network to bridge their expansion domestically as well as overseas. Investment Criteria Focus on Early Stage and Growth phases rounds for companies offering innovative products / services operating within a large addressable market. Target investments should ideally have potential for international expansion.

Delirus Capital is a founder-focused investment firm that provides early-stage funding to exceptional founders across Europe, the UK, and the US.Delirus Capital helps to invset in consumer-focused businesses where it could draw on its branding and community-building experience.

Pi Campus was established with the profits generated by Marco Trombetti, Isabelle Andrieu, and Gianluca Granero from their previous businesses. Initially, it was the investment arm of Translated, a translation service that pioneered the use of artificial intelligence to help professional translators. After a few years, things started growing very fast and the VC firm was created. We invest in Europe and the US, without any constraints regarding how much and when to invest. Nor do we plan to exit in advance. We invest mostly in AI, but if your startup is growing incredibly fast, it would be our pleasure to meet you anyway.

Braavos Investment Advisers is an investment firm specializing in providing advisory services to institutional investors and high-net-worth individuals. The firm offers tailored investment advice, portfolio management, and strategic financial planning solutions. Braavos Investment Advisers leverages its expertise in financial markets and asset management to help clients optimize their investment strategies and achieve their financial goals. With a client-focused approach, the firm emphasizes personalized service and prudent risk management to preserve and grow clients' wealth over the long term. For more information about their services and approach to investment advisory, visiting their official website or contacting Braavos Investment Advisers directly would provide comprehensive insights into their offerings and expertise.

Scalebridge Capital is an early-stage VC fund specializing in investing in artificial intelligence (AI) and workflow automation solutions for legacy industries. The firm focuses on supporting startups and companies that innovate in these areas, aiming to modernize traditional sectors by leveraging AI technologies and enhancing workflow efficiencies. Scalebridge Capital provides strategic capital, mentorship, and operational guidance to help startups scale their innovations and achieve market leadership. With a dedicated focus on AI and workflow automation, the firm plays a pivotal role in driving digital transformation and technological advancements across industries. For entrepreneurs and startups in AI and automation seeking early-stage funding and industry expertise, Scalebridge Capital offers tailored support to accelerate growth and innovation.

Blue Lake is a venture capital firm dedicated to investing in and supporting exceptional immigrant founders at the pre-seed and seed stages in the UK. Specializing in B2B and software startups, Blue Lake provides strategic capital and hands-on support to early-stage companies poised for rapid growth. With a commitment to fostering diversity and innovation, Blue Lake leverages its deep industry knowledge and network to empower immigrant entrepreneurs in building scalable and impactful businesses that thrive in competitive markets.